been identified. Among these, the gene encoding the α-isoform catalytic subunit (PIK3CA, p110α) was found to be frequently mutated or amplified, leading to the acquisition of oncogenic properties or increased tumor aggressiveness. 8, 9 PIK3CA mutation and amplification in gastric cancer have also been described;
in particular, the amplification of PIK3CA is frequently observed in gastric adenocarcinoma. 10, 11 PIK3CA mutation and amplification in gastric cancer can act as a driver mutation, and they are associated with carcinogenesis and adverse prognosis. 12, 13 In gastric cancer, dysregulation of the PI3K-Akt pathway due to PIK3CA mutation and inactivation of the phosphatase and tensin homolog (PTEN) has been identified as a mechanism for trastuzumab resistance. 14 Moreover, aberrant increase in PIK3CA immunoreactivity can promote gastric cancer metastasis. 9 Here, we investigated PIK3CA expression in human gastric cancer tissue using immunohistochemistry. We evaluated the relationships between PIK3CA expression level and the conventional clinicopathological parameters, as well as effects on patient survival. In addition, we sought to determine the use of PIK3CA immunohistochemistry to predict the clinical outcome of gastric cancer.
Materials and Methods
Patients and specimens
For this retrospective study, we enrolled a consecutive series of 178 gastric cancer patients. Gastric adenocarcinoma was confirmed using histology for all patients. All patients underwent total or subtotal gastrectomy at the Soonchunhyang University
Cheonan Hospital between July 2006 and December 2012. The patients had a mean age of 61 years (range, 27 to 81 years). They were regularly followed every 6 months or yearly after surgery, and their mean follow-up period was 58 months (range, 0 to 95 months 
Tissue microarray construction
Tissue microarrays (TMA) were prepared as previously described. 15 H&E-stained slides were evaluated under light microscopy to define representative and non-necrotic areas in the tumors. Single tissue cores (2 mm in diameter) were obtained from paraffin blocks (donor block) and transferred to a recipient block using a trephine apparatus (Superbiochips Laboratories, Seoul, Korea). Cores of non-tumorous gastric mucosa tissue were included and assembled between the tumor cores. Final scores of ＜4 were considered negative, whereas scores of ≥4 were considered positive. 16 For negative controls, 18 normal gastric mucosa cores were included in the TMA blocks. PIK3CA immunoreactivity score of these cores ranged from 0 to 3. Additionally, non-tumorous mucosa adjacent to the tumor core showed no immunoreactivity or weak PIK3CA-positive staining in contrast with the tumor glands (Fig. 2 ).
Immunohistochemical staining and assessment

Statistical analysis
All statistical analyses were performed using the PASW ver. 
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Fig. 2. (A, B)
Normal gastric mucosa, which was used as a negative control, displayed absence of PIK3CA staining (A) or weak PIK3CA staining (B) (×200). (C) Positive PIK3CA staining in tumor glands and negative staining in the adjacent non-tumorous gastric mucosa (×200). generated using the Kaplan-Meier method with log-rank test.
Univariate and multivariate analyses were performed using the 
Survival analysis
A significant correlation between PIK3CA overexpression and poor survival was found using the Kaplan-Meier survival analysis with log-rank test. Patients that displayed positive PIK-3CA staining had worse OS than those with negative PIK3CA staining (P=0.047; Fig. 3 ). To further evaluate the prognostic implications of PIK3CA expression in gastric cancers, a univariate analysis using the Cox proportional hazard regression model was performed. In the univariate analysis, patients with positive PIK3CA staining were more likely to display reduced OS compared to those in the PIK3CA-negative group (P=0.051; hazard ratio=1.832; Table 2 ). No significant differences in OS were found between PIK3CA-positive and negative groups using a multivariate analysis (Table 3) .
Discussion
PI3K is a component of the PI3K signaling pathway that plays crucial roles in the regulation of cell proliferation, survival, and adhesion capacity, and is frequently upregulated in human cancers. 17, 18 PIK3CA, encoding the p110α subunit of PI3K, is located on chromosome 3q26.3 and mutations of this gene are common in various malignant tumors, including colon, gastric, Furthermore, a recent study that evaluated a PIK3CA mutation in esophageal cancer revealed that PIK3CA overexpression, determined by immunohistochemistry, could be utilized as an independent factor to predict high local recurrence. 21 To the best of our knowledge, the current study is second to report PIK3CA expression using immunohistochemistry and first to describe the significance of PIK3CA overexpression for gastric cancer patient survival.
In an in vitro study using a tongue cancer cell line, inhibition of PIK3CA expression was shown to suppress PTEN and Akt phosphorylations, resulting in decreased proliferative activity and invasiveness and increased drug sensitivity. 22 In gastric cancer cell lines, knockdown of PIK3CA by siRNA also led to reduced tumor cell invasion and migration, suggesting that PIK3CA expression is involved in cancer cell invasion. 23 In this study, we PIK3CA can also serve as a determinant for tumor differentiation or morphological phenotypes. In a breast cancer study, increased PIK3CA immunoreactivity was associated with highgrade morphology, as well as different histology subtypes (invasive ductal carcinoma versus other histology types). 8 A previous colorectal cancer study also reported PIK3CA overexpression in specimens with high grade histology and mucinous adenocarcinoma morphology. 16, 24 In contrast to previous studies in other organs, we observed PIK3CA overexpression in carcinomas with low grade histology (well/moderately differentiated; P=0.040).
This trend was also observed when association between the Lauren classification and PIK3CA expression was determined.
We observed positive PIK3CA staining in intestinal-type adenocarcinomas, and negative staining in mixed-and diffusetype carcinomas (P=0.001). The Lauren classification subdivides gastric cancers into diffuse-and intestinal-types based on their morphology. 25 In contrast, Tan et al. 26 reported a molecular classification of gastric cancers based on the gene expression patterns. In their study, mesenchymal-and proliferative-types were associated with diffuse-and intestinal-type adenocarcinomas, respectively. Furthermore, a recent study revealed that each
Lauren classification subtype (diffuse, mixed, and intestinal) exhibited a unique DNA methylation signature during early gastric carcinogenesis. 27 These findings suggested that the morphological characteristics of gastric cancer are induced by a variety of unique genetic or epigenetic alterations. Therefore, we concluded that different PIK3CA expression levels among the histological subgroups can partially explain their morphological features, including tumor differentiation. However, the precise mechanism is yet to be defined.
Few studies have investigated the correlation between PIK-3CA immunoreactivity and patient survival in gastric cancer.
Several breast and colorectal cancer studies demonstrated that elevated PIK3CA expression, as observed using immunohistochemistry, was correlated with worse OS. 8, 21 Another study using a small cohort of 53 primary gastric cancer cases revealed that PIK3CA overexpression was a predictive marker for metastasis in gastric cancers; however, survival analysis was not performed. 9 We found that the PIK3CA-positive group was more likely to show worse OS than the negative group using a logrank test and univariate survival analysis (P=0.047 and P=0.051, respectively). These results suggested that the level of PIK3CA expression can reflect the prognosis of gastric cancer patients.
To summarize, PIK3CA overexpression was associated with poor survival and aggressive clinicopathological features, such as deep invasion of the gastric wall (high T stage) and lymphatic invasion. PIK3CA expression, assessed by immunohistochemistry, was observed in intestinal-type adenocarcinoma, suggesting PIK3CA role as a determinant for molecular and morphological characteristics of gastric cancer. In conclusion, PIK3CA immunochemistry may serve as a useful method to predict patient survival and aggressiveness of gastric cancer.
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